Sean Dikdan
Cardiovascular Disease · Newark, DENPI 1770017121
Payments from drug & device makers
What this record shows
This record is dominated by grants: $26,500 of the $42,066 with a category attached, or 63.0%. Medtronic accounts for 80.6% of it on its own, with 18 other manufacturers making up the rest. Among cardiovascular disease clinicians in DE with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 154 payments — averaging $273.16 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$34K
- Boston Scientific$3K
- Abbott$1K
- Biosense Webster, Inc.$773
- Medical Device Business Services, Inc.$544
- Philips North America LLC$493
- plus $2K from 13 others
What the payments were for
- Grants$26,50063%
- Travel & lodging$7,27717%
- Food & beverage$7,25717%
- Education$1,0322%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic | 74 | $33,890 |
| Boston Scientific | 21 | $3,352 |
| Abbott | 12 | $1,435 |
| Biosense Webster, Inc. | 11 | $773 |
| Medical Device Business Services, Inc. | 1 | $544 |
| Philips North America LLC | 3 | $493 |
| AstraZeneca | 3 | $343 |
| E.r. Squibb & Sons, L.L.C. | 3 | $243 |
| Biotronik Inc. | 4 | $232 |
| Shockwave Medical, Inc | 1 | $164 |
| Pfizer | 9 | $147 |
| Sanofi-aventis U.S. LLC | 1 | $109 |
| Novo Nordisk | 1 | $104 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 3 | $69 |
| Amgen | 1 | $61 |
| Lantheus Medical Imaging, Inc. | 2 | $35 |
| Novartis | 2 | $29 |
| Livanova USA, Inc. | 1 | $22 |
| Actelion Pharmaceuticals US, Inc. | 1 | $21 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Micra$2,336
- EVERA MRI XT DR SURESCAN$1,295
- Carto 3$1,118
- VersaCross Access Solution$963
- ENSITE$553
- (9520) IGT Devices Undivided$444
- THORATEC HEARTMATE 3 LVAS IMPLANT KIT$311
- AVEIR$243
- AURORA EV-ICD MRI SURESCAN$175
- Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter$164
- Acticor 7 VR-T DX$150
- FARXIGA$123
- BRILINTA$117
- CAMZYOS$105
- Ozempic$104
How this compares
$42,066 in reported general payments places this provider in the 90th percentile of 104 cardiovascular disease providers in Delaware.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Metoprolol Succinate | 21 | $143 |
Paid to pharmacies, not to this prescriber.
Other cardiovascular disease in Newark
- Edward GoldenbergNewark$52K
- Muhammad ShakirNewark$47K
- Anthony AlfieriNewark$45K
- Kirk GarrattNewark$38K
- Anthony ClayNewark$37K
- Ashish ParikhNewark$26K
- William WeintraubNewark$24K
- Wen Chi TsaiNewark$20K
- Stephen MengNewark$17K
- Francis PalermoNewark$17K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.